Applications of 4-Chloro-2-Phenylquinazoline in Industrial Manufacturing

We produce 4-Chloro-2-Phenylquinazoline to support select downstream sectors requiring consistent purity and traceability in API intermediates and advanced specialty chemicals. Our technical team collaborates directly with client formulation, QC, and regulatory staff to help integrate this compound into established production environments, ensuring compliance, process reliability, and supply-chain transparency. Below, we detail major industrial applications where this molecule is a recognized component of validated production routes.

1. Targeted Oncology Active Pharmaceutical Ingredient (API) Intermediate

4-Chloro-2-Phenylquinazoline serves as a critical intermediate in synthesizing several quinazoline-based kinase inhibitors for cancer treatment. Downstream pharmaceutical companies incorporate it during multistep syntheses of patent-protected APIs, using our high-purity specification to minimize process impurities. Customers validate material origin through full batch documentation for regulatory filings, while customizing process input ratios based on the required stoichiometry and yield optimization during the heterocyclic coupling step. Rigorous analytical controls ensure consistent impurity profiles aligned with ICH guidelines and product master files.

Industry compliance standards

• ICH Q7 GMP (Good Manufacturing Practice) for Active Pharmaceutical Ingredients
• US FDA 21 CFR Part 211 for finished pharmaceuticals
• European Pharmacopeia (Ph. Eur.) cross-references for impurity limits in synthesis steps
• Japan PMDA regulatory guidance for API starting materials

Typical usage ratio

• Employed at 0.7–1.2 equivalents relative to primary nucleophile; adjustment based on process yield and required purity of downstream intermediate.

Downstream process integration

• Introduced in the nucleophilic aromatic substitution step following initial quinazoline ring formation. Involves controlled addition under inert atmosphere with temperature ramp and in-process monitoring of conversion rate.

Final product types

• Small-molecule oncology APIs such as epidermal growth factor receptor (EGFR) inhibitors
• Specifically: gefitinib and similar advanced kinase inhibitor agents
• Regulatory-submitted drug substance intermediates

2. Advanced Agrochemical Synthesis Intermediate

Agrichemical producers use 4-Chloro-2-Phenylquinazoline as a key building block in the custom synthesis of heterocyclic pesticides, notably for the construction of azine-containing herbicide scaffolds. Technical requirements in this sector demand high chemical purity and trace heavy metal limits due to environmental impact assessments. Process chemists adjust loading amounts depending on the specific reactivity of the coupling partner and seasonal active ingredient demand, with batch records prepared under ISO-certified procedures for traceability from raw material through field formulation.

Industry compliance standards

• FAO and WHO pesticide specification standards
• ISO 9001:2015 quality management for agrochemical manufacturing
• EU Regulation (EC) No 1107/2009 for plant protection product registration
• China GB/T 1601 quality standard for pesticide intermediates

Typical usage ratio

• Applied at 1.0–1.3 molar equivalents per target active intermediate, precisely weighed to match field-specific formulation loads per campaign requirements.

Downstream process integration

• Added during the first heterocycle assembly in multi-step flow synthesis systems, monitored for residual unreacted precursor to control downstream selectivity and minimize byproduct carryover into final technical concentrate.

Final product types

• Azine-based herbicide active ingredients
• Pre-emergent weed control agents incorporating quinazoline backbones
• Bulk pesticide intermediates for external formulation

3. Specialty Dye Manufacture—Quinazoline-Based Chromophore Intermediate

4-Chloro-2-Phenylquinazoline plays an instrumental role in the creation of specialty dyes used in advanced printing inks and textile coloration, particularly for demanding markets in security and industrial apparel applications. Dye manufacturers require this raw material to meet internal performance and migration standards, with incoming quality controlled for residue solvents and color index alignment. Typically, its inclusion is determined by targeted chromatic shade, solubilizer compatibility, and downstream customer ink system parameters.

Industry compliance standards

• OEKO-TEX® Eco Passport for dye raw materials
• ISO 2836:2021 (Resistance of printed materials to solvents and chemicals)
• REACH Annex XVII restrictions for dye intermediates
• ZDHC MRSL (Zero Discharge of Hazardous Chemicals Manufacturing Restricted Substances List)

Typical usage ratio

• Used at 2–6% of total dye batch input; actual ratio varies according to desired chromophore intensity, shade, and printing application requirements.

Downstream process integration

• Reacted as the principal heterocyclic ring donor in dye coupling stages, following initial colorant backbone synthesis, with in-line spectral verification prior to pigment precipitation or liquid ink blending.

Final product types

• High-performance printing inks for industrial digital presses
• Reactive dyestuffs for technical textile finishing
• Anti-counterfeit pigments for brand protection packaging

4. API Intermediate for Central Nervous System (CNS) Drug Development

In the pharmaceutical industry’s CNS sector, 4-Chloro-2-Phenylquinazoline is utilized by research-based pharmaceutical manufacturers in the production of clinical-stage molecules intended for neurological and psychiatric disorders. The downstream integration focuses on precision-controlled reactions during early-stage synthetic route definition and successful scale-up for GMP-compliant production, with quality specifications tailored to limit genotoxic impurities and batch variability for IND submissions and pilot-scale batch records.

Industry compliance standards

• ICH M7 guidance for control of DNA-reactive (mutagenic) impurities
• US FDA IND requirements for clinical trial materials
• EMA GMP guidelines for investigational medicinal products
• USP Chapter <467> on residual solvents

Typical usage ratio

• Dosed at 0.9–1.1 equivalents, selected during route scouting and process validation to minimize off-target reactivity and facilitate purification of target CNS-active intermediates.

Downstream process integration

• Introduced at the controlled substitution stage in heterocycle extension, with post-reaction purification and analytical release testing conducted before scale-up to GMP kilo-lab or pilot plant batches.

Final product types

• Lead candidate CNS drug substance intermediates
• Pharmaceutical substances for Phase I/II neuroactive compound trials
• Research-grade intermediates for contract research and manufacturing organizations (CRO/CMO)

5. Chemical Intermediate for Photoactive Electronic Materials

Manufacturers of specialty electronic and photoactive materials rely on 4-Chloro-2-Phenylquinazoline for the construction of heterocycle-based electron donor-acceptor systems. In the production of advanced organic semiconductors or photoinitiators, this compound’s high purity and consistent crystallinity support precise electronic property control and batch reproducibility. Quality teams use our documentation packet for RoHS compliance and batch conformity to performance verification standards used in microfabrication environments.

Industry compliance standards

• IEC 62474 for material composition in electrical products
• EU RoHS Directive (Restriction of Hazardous Substances) for electronics raw materials
• REACH registration for specialty chemical intermediates
• ISO 9001:2015 for chemical supply to electronics industry

Typical usage ratio

• Typically used at 1–4% by mass of target organic component; ratio adjusted according to desired device characteristics and photophysical parameters in formulation trials.

Downstream process integration

• Added during initial heterocycle synthesis and side-chain modification steps prior to vacuum deposition or spin-coating operations in thin film fabrication lines.

Final product types

• Organic photoinitiators for UV-curable coatings
• Electron-transport materials in displays and sensors
• Polymer-based photonic device components